Podcasts about Tandem

We've got an update from Tandem Diabetes. We're talking about Libre 3 plus integration, Lyumjev approval, Mobi tubeless, extended wear infusion sets and a lot more with VP of Product Management Marisa Fienup. She's also answering your questions about tubing, alerts, and shares what's next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Information on RocketAP and other closed loop research Tandem earnings call info here  Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

La entrada Mimolive Owncast el tandem perfecto se publicó primero en Blog Xavi74.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Ein Polizist schießt, er und ein 29 Jahre alter Mann müssen später schwer verletzt ins Krankenhaus gebracht werden. Eine Verkehrskontrolle in Aßlar-Bechlingen im Lahn-Dill-Kreis ist gestern Abend völlig eskaliert. Tag und Nacht, ohne Pause - in der Evangelischen Kirche in Marburg wird seit gestern Abend die ganze Bibel gelesen. Pfarrer, Gemeindemitglieder und Freiwillige wechseln sich beim Lesen ab. Bis Samstag wollen sie mit den über 1.400 Seiten der Bibel durch sein. Der Landkreis Marburg-Biedenkopf macht dieses Jahr zum 1. Mal beim DUO DAY mit - an dem Aktionstag arbeiten Menschen mit Behinderung im Tandem mit einer Person aus einem regionalen Unternehmen zusammen.

Pravděpodobný příští premiér Andrej Babiš (ANO) chce obnovit společná zasedání české a slovenské vlády. Ta byla v minulém roce přerušena kvůli neshodám v klíčových zahraničních tématech, především v otázce války na Ukrajině. „Je to kaňka, která bude doufám brzy napravena,“ oceňuje místopředseda hnutí ANO Radek Vodnráček Babišův záměr. „Ať vztahy obnoví, ale neuškodí tím české pozici,“ apeluje v Pro a proti Českého rozhlasu Plus europoslanec Jan Farský (STAN).

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Pravděpodobný příští premiér Andrej Babiš (ANO) chce obnovit společná zasedání české a slovenské vlády. Ta byla v minulém roce přerušena kvůli neshodám v klíčových zahraničních tématech, především v otázce války na Ukrajině. „Je to kaňka, která bude doufám brzy napravena,“ oceňuje místopředseda hnutí ANO Radek Vodnráček Babišův záměr. „Ať vztahy obnoví, ale neuškodí tím české pozici,“ apeluje v Pro a proti Českého rozhlasu Plus europoslanec Jan Farský (STAN).Všechny díly podcastu Pro a proti můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

In einem Monat will die AfD ihre neue bundesweite Jugendorganisation gründen - und zwar in Gießen. Das Treffen beschäftigt die Stadt und die Behörden schon jetzt. Das Unternehmen Weber Food Technology aus Breidenbach schneidet Wurst, Käse aber auch vegane Produkte scheibchenweise - und das weltweit mit höchster Präzision. Dafür ist es jetzt ausgezeichnet worden - als Hidden Champion. In Gießen fehlen rund 400 Kitaplätze - Um gegen den Mangel etwas zu tun, startet das Freiwilligenzentrum ab November ein Betreuungstandem.

Welcome to the Thousand Stories podcast, the Renaissance Series.Join host Justin Brown, former Secretary of Human Services for the state of Oklahoma, and his new co-host, Luke Williams, President of Tandem Research, as they explore a true rebirth for human services.The Renaissance Series is dedicated to illuminating the stories and ideas that define this new era of innovation and transformation. We are moving toward a connected, human-centered, and innovative future in health and human services (HHS). We explore how leaders, researchers, and practitioners are building systems that truly serve people.Justin Brown originally launched the Thousand Stories podcast to share the incredible untold stories happening in Health and Human Services beyond the challenges and negative headlines. Now, the conversation centers on the belief that we are at the dawn of a renaissance in HHS, positioned at the intersection of experienced leadership and new technology innovations that can supercharge this transformation.The mission is to rethink the current system, which often operates as a "one-size-fits-all approach" that catches people at the bottom. Instead, we advocate for a custom safety net that follows us wherever we go, employing strategic interventions. This shift is essential for promoting dignity, creating better outcomes for future generations, and achieving greater efficiency for taxpayers.To achieve this, we must focus on delivery model transformation by working to remove systemic barriers (like those related to transportation, language, child care, and stigma) that prevent customers from accessing resources. A core goal is to move upstream to a more preventative posture, meeting people before they fall into crisis, preventing engagement with intrusive systems like child welfare.This series draws heavily on the research conducted by Luke Williams and Tandem Research, including their national catalog of delivery model innovations that covers 46 cases across over 38 states.In this episode, the hosts focus on the physical delivery of health and human services and the eight categories of innovation currently reshaping the field:Community Partnerships: Services delivered through formal agreements with local nonprofits, sometimes utilizing embedded workers or licensed nonprofit workers.Collocation: Partnerships between public entities, such as the one-stop shop model.Real Estate Modernization: Strategically streamlining physical office space, often coupled with distributing the workforce into the community.Mobile Service Delivery: Utilizing gutted buses or vans to provide intake and eligibility determinations in rural areas, disaster areas, or to alleviate the burden on overwhelmed physical offices.Intensive Case Management: Giving workers the tools to develop long-term career or educational pathways.Integrated Online Portals: Utilizing tools like robotic process automation (RPA) and AI for proactive intake and eligibility identification across services and agencies.Modernized Contact Centers: Using AI as a "switchboard operator" or "front man" to direct callers to specialized human teams.Tech-Driven Case Management: Using emerging technologies like AI to analyze customer data for predictive capabilities (e.g., anticipating a life event that changes service eligibility) or detecting fraud.While technology is a critical component for systems to move upstream, the hosts emphasize that the physical in-person experience is critical and will remain important for the foreseeable future, making intentional planning for the physical footprint essential. Discover how leaders are creating a meaningful and intentional mix of purpose-built physical spaces and distributed models to serve people at their most vulnerable times.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

In Part 2, Ian Wookey takes us inside daily flying with 450 Tactical Helicopter Squadron, sharing what it's like to operate the CH-147F Chinook in challenging environments. He talks about crew coordination, tactical missions, mountain flying, and the training and experience required to upgrade from First Officer to Aircraft Commander in Canada's heavy-lift helicopter community. 

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

We get into the world of Tandem adventures with Di and Colin, a dynamic duo from Scotland who first rode a tandem bike on a blind date and haven't looked back since. They share about their adventures through the UK and France, and how a recent stage 4 Prostate Diagnosis has focused them more sharply on continuing to live life to the full. Follow them on the socials - FacebookRead their blog - Matilda's MusingsDonate to their fundraiserCheck out Zorali for all your outdoor adventure needs! Check out Ombraz Sunglasses - I'm a fan and I think you will be too!Support the showBuy me a coffee! I'm an affiliate for a few brands I genuinely use and recommend including:

Wir sprechen über aktuelle Lichttechnik am Fahrrad und das High Velocity Research, ein Rennen für Räder aus Resten. (00:00:00) Begrüßung (00:02:21) Klingeln bei Klötzer: Fahrradlicht (00:03:39) Der wichtigste Tipp: Licht richtig einstellen (00:09:30) Stand der Technik bei Dynamo-Scheinwerfern (00:12:18) Rücklichter für Dynamo (00:13:13) Akku-Frontlichter (00:15:33) Akku-Rücklicht (00:22:00) Verschiedenes zur Zukunft am Lichtmarkt (00:32:34) Nachtrag zu Menschen zu Fuß und im Rollstuhl (00:33:36) Ausfahrt des Monats: High Velocity Research (00:35:29) Glücksrad und Wundertüten (00:40:02) Pauls 29er Hardtail (00:41:26) Tonis 20-Zoll-Rad (00:44:04) Inspiration durch das Hack Bike Derby (00:47:24) Das Mini Bike Fest (00:51:39) Nachbesprechung und Einladung ins Peloton (00:52:50) Musik: Wet Leg – mangetout Hier findet ihr einen Bericht zum High Velocity Research: https://bikepacking.com/plog/high-velocity-research-trash-metal-framebuilding-competition-2025/ Hier findet ihr mehr zum Mini Bike Fest der 20inch_ultras: https://www.instagram.com/mini_bike_fest/ Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-licht-am-fahrrad-und-high-velocity-research

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Wir sprechen über aktuelle Lichttechnik am Fahrrad und das High Velocity Research, ein Rennen für Räder aus Resten. (00:00:00) Begrüßung (00:02:21) Klingeln bei Klötzer: Fahrradlicht (00:03:39) Der wichtigste Tipp: Licht richtig einstellen (00:09:30) Stand der Technik bei Dynamo-Scheinwerfern (00:12:18) Rücklichter für Dynamo (00:13:13) Akku-Frontlichter (00:15:33) Akku-Rücklicht (00:22:00) Verschiedenes zur Zukunft am Lichtmarkt (00:32:34) Nachtrag zu Menschen zu Fuß und im Rollstuhl (00:33:36) Ausfahrt des Monats: High Velocity Research (00:35:29) Glücksrad und Wundertüten (00:40:02) Pauls 29er Hardtail (00:41:26) Tonis 20-Zoll-Rad (00:44:04) Inspiration durch das Hack Bike Derby (00:47:24) Das Mini Bike Fest (00:51:39) Nachbesprechung und Einladung ins Peloton (00:52:50) Musik: Wet Leg – mangetout Hier findet ihr einen Bericht zum High Velocity Research: https://bikepacking.com/plog/high-velocity-research-trash-metal-framebuilding-competition-2025/ Hier findet ihr mehr zum Mini Bike Fest der 20inch_ultras: https://www.instagram.com/mini_bike_fest/ Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-licht-am-fahrrad-und-high-velocity-research

Wir sprechen über aktuelle Lichttechnik am Fahrrad und das High Velocity Research, ein Rennen für Räder aus Resten. (00:00:00) Begrüßung (00:02:21) Klingeln bei Klötzer: Fahrradlicht (00:03:39) Der wichtigste Tipp: Licht richtig einstellen (00:09:30) Stand der Technik bei Dynamo-Scheinwerfern (00:12:18) Rücklichter für Dynamo (00:13:13) Akku-Frontlichter (00:15:33) Akku-Rücklicht (00:22:00) Verschiedenes zur Zukunft am Lichtmarkt (00:32:34) Nachtrag zu Menschen zu Fuß und im Rollstuhl (00:33:36) Ausfahrt des Monats: High Velocity Research (00:35:29) Glücksrad und Wundertüten (00:40:02) Pauls 29er Hardtail (00:41:26) Tonis 20-Zoll-Rad (00:44:04) Inspiration durch das Hack Bike Derby (00:47:24) Das Mini Bike Fest (00:51:39) Nachbesprechung und Einladung ins Peloton (00:52:50) Musik: Wet Leg – mangetout Hier findet ihr einen Bericht zum High Velocity Research: https://bikepacking.com/plog/high-velocity-research-trash-metal-framebuilding-competition-2025/ Hier findet ihr mehr zum Mini Bike Fest der 20inch_ultras: https://www.instagram.com/mini_bike_fest/ Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-licht-am-fahrrad-und-high-velocity-research

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

In the conclusion of this two-part story, we talk with "Brian" who will share about his work with Dana Brown, Executive Director of Tandem's Mentorship about the challenging but important work of restorative justice.  Brian's story highlights how cultural norms can influence the perpetration of sexual crimes but finally how accountability, empathy, and community support can bring validation and restoration to survivors while helping prevent future harm. We hope this story sparks conversations that support survivors, challenge harmful norms, and encourage prevention. Learn more at fiercefreedom.org

Ever wondered what it would be like to travel through a country on a Tandem bicycle? This week Federico and Baaska are going to tell us all about their experience and a day cycling in MalaysiaFollow them on instagram - @Fedenbaaska I'm also shouting out fans who responded to my Instagram Question - What is your luxury item for bike travel.Check out Zorali for all your outdoor adventure needs!Support the showBuy me a coffee! I'm an affiliate for a few brands I genuinely use and recommend including:

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

In Part 1, pilot Ian Wookey walks us through the formative years that made him a Chinook aviator - from varsity life at RMC and initial flight training on the Grob, to the intensity of the Harvard II course in Moose Jaw and the humbling challenge of helicopter phase training. Ian reflects on early on-the-job roles, an unexpected deployment to Afghanistan with a special operations aviation detachment, and how those experiences shaped his choice to fly rotary-wing aircraft. He closes by describing the nerve-wracking moment of selection for the CH-147F Chinook and what it felt like to join 450 Tactical Helicopter Squadron. 

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

BT and Sal dive into the Aaron Glenn debate, energized by a caller who suggests the Jets coach isn't "scared to lose, but scared to win." The hosts dissect Glenn's seemingly hesitant decision-making, comparing him to Brian Daboll's fearless, early-career gambles. While acknowledging that Justin Fields' poor play is a factor, they argue Glenn is not absolved from making "horrific decisions." The conversation quickly escalates into a "Harbaugh Watch," with Sal questioning whether the Jets should pull the plug on Glenn after one season if a known commodity like John Harbaugh unexpectedly becomes available. Plus, a quick look at the Jets' possible trade targets (Olave, Waddle) and a preview of the upcoming Yankees press conference with Boone and Cashman.

The Alan Cox ShowSee omnystudio.com/listener for privacy information.

The Alan Cox Show

In this two-part episode, we talk with "Brian" who will share about his work with Dana Brown, Executive Director of Tandem's Mentorship about the challenging but important work of restorative justice.  Brian's story highlights how cultural norms can influence the perpetration of sexual crimes but finally how accountability, empathy, and community support can bring validation and restoration to survivors while helping prevent future harm. We hope this story sparks conversations that support survivors, challenge harmful norms, and encourage prevention. Learn more at fiercefreedom.org

In this episode of Your Diabetes Insider Podcast, Ben breaks down everything you need to know about insulin pumps - what's out there, how they work, and whether switching from injections is worth it. He covers the pros and cons of top options like Omnipod, Tandem, and Medtronic, shares real talk on convenience vs. reliability, and gives tips for figuring out which system fits your lifestyle best. If you've ever wondered, “Should I get a pump—or stick with shots?” this episode will help you decide. Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching   RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff Watch my food breakdowns here → https://www.youtube.com/@yourdiabetesinsider   LET'S TALK! Instagram: @manoftzeel Tiktok: @manoftzeel

Leslie shares her teen's type 1 diabetes diagnosis and DKA, rapid self-management with Dexcom G7 and Tandem t:slim Control-IQ, ADHD challenges, camp chaos, and parenting tactics that build independence. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

In this episode, Lex speaks  Mike Sha - the CEO and co-founder of Tandems (formerly SigFig), a leading provider of AI-powered software for wealth management firms and financial institutions. Together, Lex and Mike discuss the evolution of wealth technology through the lens of Mike's entrepreneurial journey from founding Wikinvest in 2006 to building Tandems. Wikinvest pivoted to portfolio tracking and then to a B2B model, powering major portals like Yahoo Finance and managing over $500 billion in tracked assets. The team's insights into poor retail investment behavior led to building SigFig, a B2B robo-advisor, eventually serving banks like UBS and Wells Fargo.Today, rebranded as Tandems, the firm offers AI-powered tools for advisors across three key areas: meetings, asset gathering, and investment management, with AI integrated via a modular “wealth OS” platform. Tandems uses an open architecture for AI, prioritizing trust, configurability, and high accuracy tailored to the specific workflows of financial advisors. NOTABLE DISCUSSION POINTS:The Realization That Most Investors Struggle on Their Own Sparked the Robo-Advisory Movement - Mike Sha's early data from tracking $400–500 billion in retail portfolios across Yahoo!, CNN, and other finance portals revealed that most individuals consistently underperform when managing their own investments. This insight directly led to the creation of SigFig, one of the first robo-advisors, designed to make high-quality investment advice affordable and automated. It shows how data-driven observation of user behavior can uncover market inefficiencies and spark new product categories.Distribution and Integration Trumps Pure Innovation in Fintech Partnerships - Tandem's evolution from a consumer-facing platform to a B2B software provider for major banks underscored a critical lesson: distribution and trust are the hardest parts of scaling in financial services. Rather than trying to replace institutions, Sha's team embedded within them - learning that success requires deep integration with legacy systems and respect for the bank's compliance and operational frameworks. The “secret” to working with large financial institutions, Sha notes, is understanding their old infrastructure and designing around it - not fighting it.AI's Real Impact in Wealth Management Will Begin with Eliminating Repetitive Work - Tandem's current strategy focuses on AI automation for financial advisors, not as a replacement but as an assistant. Sha highlights that over 90% of an advisor's day involves repetitive administrative work - meeting prep, paperwork, compliance, follow-ups. Tandem's “Wealth OS” connects legacy systems and uses AI to automate these tasks first, freeing advisors to focus on human relationship-building and advice. It's a practical and near-term vision of AI in finance: efficiency before intelligence. TOPICSTandems, SigFig, Wikinvest, wealthtech, wealth management, fintech, ai, artificial intelligence, investment, roboadvisors, finance, financial management, banking, bank partnerships ABOUT THE FINTECH BLUEPRINT

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.   Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said.   “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.”   Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.   https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas.   The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/     XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay     XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition.   G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.   The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.   "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes.   The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting  it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems.   https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.).   – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. ​This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November.   ​ https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/   XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. ,   The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say.   In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries."   The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours.   Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy.   At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy.   Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells.   Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially.   Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells.   “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release.   “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy   XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification

The Go Gopher Podcast with Mike Grimm - Episode #190 features a return visit from Gopher football tight end Jameson Geers, who brings fellow tight end Drew Biber along with him.  We recap the Rutgers win and preview this weekend's game at #1 Ohio State.   From Aquarius Home Services Studio (https://aquariushomeservices.com/)   Sponsored by: (https://www.sunbeltminnesota.com/ & https://www.tnma.com), Affinity Plus Federal Credit Union (https://www.affinityplus.org/gogophers), OnX Maps (https://www.onxmaps.com/), & Cub Foods (www.cubfoods.com)

This week on Happy Mum Happy Baby we say hiya to actress, presenter and mother of four Joanna Page!Joanna opens up to Gi about life after Gavin & Stacey, and shares how she juggles the chaos of raising four children (and many pets!) alongside her acting career.She also reflects on the complications she faced during pregnancy, as well as her experience of becoming pregnant again at 44.Joanna's new autobiography Lush!: My Story - From Swansea to Stacey and Everything in Between is available now! Hosted on Acast. See acast.com/privacy for more information.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

When roles shift at home and at work, even strong couples can feel the strain. In this episode, returning guests Shay and Phil Bynes (Kingdom Driven Entrepreneur) pull back the curtain on their four-year journey of transitioning Shay out of the CEO seat and Phil in—while raising three kids and continuing to lead a global movement. They share what changed, what didn't, and how they protected connection through it all. You'll hear how they navigated identity, authority, and expectations as spouses and co-leaders—without letting business tension become marital tension. From hearing God's nudge to act, to wrestling with control, to defining new decision rights, Phil and Shay explain the practical guardrails (and plenty of grace) that made the handoff work. We also get tactical about staying close during busy seasons: weekly “marriage board meetings,” spontaneous micro-check-ins, and simple, intentional fun that doesn't require a plane ticket. If you're a married entrepreneur aiming to grow your business without shrinking your marriage, this conversation is a masterclass in change done together. 12 Powerful Questions to Connect You with God's Heart & Mind in Business: https://kingdomdrivenentrepreneur.com/usccc Free Chapter of Shae's Book, Grace Under Pressure: A Story About Leadership and the Hidden Cost of Ambition https://shaebynes.com/gupbook Grace over Grind https://kingdomdrivenentrepreneur.com/our-books/ Key Takeaways: Transitions need clarity: Decide who owns which decisions now (vision, people, money, operations) and write it down. Step back—then calibrate: Founders often swing too far away after a handoff; expect to iterate until the advisor/CEO rhythm fits. Protect a weekly marriage meeting: Same time, same day, non-negotiable. Use ground rules so issues get resolved before they fester. Honor design differences: Lead styles will differ by God's design; resist the urge to “correct” your spouse into your style. Let things “sputter” (strategically): Maturity sometimes requires leaders to stop rescuing, so teams learn to think and own outcomes. Friendship fuels connection: Micro-moments (10-minute check-ins, pausing a show to talk) keep intimacy alive during busy stretches. Serve first leadership: Out-serving one another at home creates safety and teamwork that shows up in the business. Plan fun on purpose: Comedy nights, simple dates, and kid-care logistics belong on the calendar like any key meeting. Phil Bynes is CEO of Kingdom Driven Entrepreneur, a global movement equipping entrepreneurs to partner with God in business and create greater Kingdom impact in the marketplace. He is also the owner and lead therapist at Crazy Good Massage, where he has served clients with excellence for over 20 years. Shae Bynes, affectionately known as the Chief Fire Igniter, equips leaders to build grace-empowered cultures where people and results flourish. She has impacted over one million people worldwide through her books, courses, podcasts, and speaking. In her executive advising work, she brings a unique blend of strategic clarity, spiritual intelligence, and transformational insight. High school sweethearts since age 16, Phil and Shae have been married for 26 years and are the proud parents of three daughters. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk  

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

The Race is back ! For the kickoff of The Amazing Race Season 38, Brice is switching things up on the Pitstop. While Brooke is living her best life in Europe, our good friend Sasha Joseph (@funsize_04) steps in to break down all the twists and turns of Episode 1. From icy strikes on the rink, cheese wheels in Edam, to flower power in the greenhouse, Brice and Sasha are just vibin' as they unpack the premiere. We're talking Express Pass drama, Hazard struggles, and first impressions of this Big Brother–meets–Race cast. You already know the vibes are high and the energy is flowing—don't miss it!

Purple Pants Podcast | Twins, Twists & Tandem Bikes The Race is back ! For the kickoff of The Amazing Race Season 38, Brice is switching things up on the Pitstop. While Brooke is living her best life in Europe, our good friend Sasha Joseph (@funsize_04) steps in to break down all the twists and turns of Episode 1. From icy strikes on the rink, cheese wheels in Edam, to flower power in the greenhouse, Brice and Sasha are just vibin' as they unpack the premiere. We're talking Express Pass drama, Hazard struggles, and first impressions of this Big Brother–meets–Race cast. You already know the vibes are high and the energy is flowing—don't miss it! You can also watch along on Brice Izyah's YouTube channel to watch us break it all down https://youtube.com/channel/UCFlglGPPamVHaNAb0tL_s7g Previously on the Purple Pants Podcast Feed:Purple Pants Podcast Archives LISTEN: Subscribe to the Purple Pants podcast feed WATCH: Watch and subscribe to the podcast on YouTubeSUPPORT: Become a RHAP Patron for bonus content, access to Facebook and Discord groups plus more great perks! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Rebecca and Shaun catch up on life, business, and creative growth. Rebecca just returned from a design retreat at a beautifully designed cabin (by Form & Field), where she worked on brand strategy and made tangible progress on her website. They also dive into frustrating vendor experiences, the evolving role of AI agents in design work, and a hot take on whether being barefoot in brand photos is ever appropriate.In the second half of the episode, they debate the ethics, emotional labor, and financial risks that come with sourcing, receiving, and delivering furniture—especially when imperfections, shipping issues, and miscommunications arise. They also explore how one small branding detail like footwear in photos can signal so much about professionalism, identity, and client expectations.In this episode they discuss:Rebecca's design retreat: goals, structure, productivity, and what she accomplished (brand strategy guide, website refresh)The importance of having external accountability (“show and tell” among designer friends) to push projects forwardChallenges working with vendors and receiving warehouses: damaged goods, imperfect manufacturing, inspection failures, and the cost (financial & emotional) of fixing themWhy healthy project and product margins are non-negotiable in design to absorb unexpected costsThe rise of AI agents in business: potential, limitations, risks (data access, automation gone wrong)The debate on brand photo styling: barefoot vs shoes, what each choice communicates about professionalism and personal brandReflections on aging, style evolution, and gaps in the market (e.g. men's clothing quality and age-appropriateness)Mentioned:The Airbnb Rebecca stayed in for her retreathttps://formandfield.com/work/donner-lake-cabinRebecca worked on her brand guide based on ideas from Renee Bush from Tandem. Listen to Renee's episode 150https://podcasts.apple.com/us/podcast/150-renee-bush-from-tandem-on-building-cohesive-brands/id1505427626?i=1000717943157Agents in AIhttps://www.tiktok.com/t/ZT6u2YScK/Our links:Subscribe and leave a review - Apple PodcastsLike, Comment, & Follow - Hot Young Designers Club InstagramRebecca's InstagramShaun's InstagramFor more information - Check out the websiteBecome a “Loyal Hottie” - Support us on PatreonDesign Resources - Check out our shop

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Get on the waitlist for a Thriving in Tandem event near you. https://marriedentrepreneur.co/marriage-and-business-events  Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Every married entrepreneur knows the challenge of managing different energy levels—especially when one spouse is ready to go full throttle and the other needs to pace themselves. In this episode, Robert and Kay Lee get real about how this dynamic plays out in their own relationship, from social events and vacations to business strategy sessions and conferences. They reflect on their early frustrations and how intentional communication helped them transform energy differences from a source of conflict into a strength. They share practical tips for managing expectations, planning ahead, and respecting each other's rhythms—whether you're attending a networking event, hosting a retreat, or simply planning your weekend. From code words to separate cars, from downtime gaps on vacation to avoiding heavy convos at bedtime, this episode offers insight into how married couples can honor each other's needs while still pursuing shared goals. Plus, they announce new in-person events—like their upcoming wine pairing dinner, concerts in the park, and even a ski trip in 2026. If you've ever wished your spouse could just keep up (or slow down), this is the episode that will help you find peace, pace, and partnership. Key Takeaways: Don't assume your spouse should match your energy—discuss your needs and make a plan ahead of time. Rest isn't always about sleep; it can also mean freedom from rigid schedules or overstimulation. Schedule important conversations when you're both alert—avoid conflict-heavy talks late at night or during busy moments. Protect the bedroom as a place of intimacy and peace, not stress or business talk. Even high-energy spouses benefit from margin; intentional rest improves clarity, focus, and connection.

Grief's Hidden Impact On The Youngest Among Us Grief in children doesn't always look like sadness and can present even months or years after a big loss. Child therapist Natasha Daniels shares both her professional insights and personal story of loss, highlighting the challenges families face in finding the right care and working through these emotions. Part 2: Food Insecurity In The U.S: How Local Pantries And National Policy Work In Tandem Across the U.S., food pantries and nonprofits are stretched thin as more families fall into the “working poor” category, earning just above the poverty line yet unable to make ends meet. Stephanie Hoopes of United for ALICE and Camerin Mattson of the Greater Chicago Food Depository explain how local support systems and federal programs like SNAP intersect to feed the many millions of Americans in need. Viewpoints Explained: Why Are Teen Reading Scores At A 30-Year-Low? High school reading scores have dropped to their lowest level in decades, with absenteeism and screen time fueling the decline. We cover how some states are tackling the problem with early literacy reforms and teacher training. Culture Crash: What Sabrina Carpenter Learned From Jack Antonoff From disco shimmer to rock swagger, singer Sabrina Carpenter's new album shows just how far her sound can stretch. Learn more about your ad choices. Visit megaphone.fm/adchoices

Across the U.S., food pantries and nonprofits are stretched thin as more families fall into the “working poor” category, earning just above the poverty line yet unable to make ends meet. Stephanie Hoopes of United for ALICE and Camerin Mattson of the Greater Chicago Food Depository explain how local support systems and federal programs like SNAP intersect to feed the many millions of Americans in need. Learn More: https://viewpointsradio.org/part-2-food-insecurity-in-the-u-s-how-local-pantries-and-national-policy-work-in-tandem Learn more about your ad choices. Visit megaphone.fm/adchoices

When was the last time you and your spouse really laughed together? In this week's episode of Thriving in Tandem, Robert and Kay Lee dive deep into a topic too many married entrepreneurs overlook—fun. After returning from an 18-day dream vacation in Italy and hosting their first “Thriving in Tandem Date Night,” they realized just how many couples have stopped making space for joy. Between business demands, family responsibilities, and endless to-do lists, fun often gets pushed aside. Robert and Kay Lee share creative, budget-friendly ways to bring fun back into your marriage without waiting for the “perfect” time or a big trip. From driveway date nights to free concerts in the park, they remind us that joy isn't about extravagance—it's about intentionality. They also reveal how planning events for their married entrepreneur community has given them built-in reasons to prioritize their own date nights and adventures. This episode is full of practical ideas, relatable laughs, and a powerful reminder that fun is essential for a thriving marriage and business. Whether it's putting date nights on the calendar, joining in-person gatherings, or even “forcing” fun through memberships or pre-paid trips, Robert and Kay Lee challenge you to stop waiting and start creating shared memories now. Join our Thriving in Tandem event waitlist https://marriedentrepreneur.co/event-waitlist  Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Key Takeaways: Fun fuels connection – Laughter and shared experiences lower stress, boost creativity, and strengthen your bond. Intentionality is everything – If it's not on the calendar, it probably won't happen. Fun doesn't have to be expensive – Explore free and local activities; creativity counts more than cost. Community matters – Being around other married entrepreneurs creates instant understanding and encouragement. Sometimes you have to “force” fun – Pre-committing with reservations, memberships, or events helps ensure you follow through.

The Chicago White Sox Catcher Kyle Teel is breaking records as a rookie. Currently, he had a 20 base streak that only Bo Bichette has kept pace with and only rookie since Jose Abreu' rookie season in 2014. Should the White Sox extend him this offseason? Tim Kanak, Host of Fantasy Aceball Podcast, joined us to go over his top 10 nondebuted prospect rankings of the Chicago White Sox farm system.

Other Episodes You Might Like: Previous Episode - From Your Mouth to Your Gut: Hearing Health Whisper Next Episode - The Truth About Muscle and Menopause: What Every Woman Needs to Know About the Science Data More Like This - Take a Walk with a 57-year old Book Author | Just 1400 Miles    Resources: Join the Hot, Not Bothered! Challenge for your best start, restart or reset in or after menopause with 10 Days of coaching, short workouts, and clarity on how to exercise optimally. Flipping 50 Womens Retreats helps you step out of routine, challenge your body and mindset, and rediscover how you want to live midlife—supported by fitness, hormones, nutrition, and women just like you.   Date night for this couple is riding tandem on a bike for 80 days.  Even “uncoupled” and singles will enjoy this episode of inspiration. Disclaimer, you're going to want to dream bigger, take a risk, believe in yourself and have adventures after listening to this episode.  We've got some ideas for you! Check out the 2026 women's retreats here. This episode is about more than riding tandem with your partner. Prepare to be inspired.    My Guest: Lady JB Owen is an internationally bestselling author, award-winning businesswoman, celebrated humanitarian, coveted speaker, trainer, and legacy mentor. She's been recognized by Forbes, Entrepreneur Magazine, and Apple News for her mission-driven work in publishing and impact.  Peter Giesin is the co-founder and CTO at Ignite Publishing, Software Evangelist for Aspiring Authors, Author, and Adventurer. He merges technology with storytelling to empower aspiring authors worldwide. Peter is ambitiously set on a personal goal: to live to 125 years old. He has an unwavering passion for exploring the far limits of living a long and vital life.   Connect with Lady JB & Peter: Website - Ignite Facebook - Ignite You and Epic Tandem Instagram - @igniteyou.life   Questions We Answer in This Episode: [00:12:16] You're currently cycling over 4,500 kilometers on a tandem bike to Ignite Humanity - define that.  [00:14:00] What inspired you to connect your purpose with a physically and mentally demanding challenge?  [00:20:00] How has the challenge changed over the years? With age, recovery changes, how has that hit differently?  [00:25:30] How do you stay motivated and connected to your ‘why' during the hardest parts of the journey, both physically and emotionally? [00:35:220] You're proving that shared purpose can strengthen not only communities but also relationships. What lessons have you learned about partnership, resilience, and communication while pedaling thousands of kilometers together? [00:45:56] People are inspired by your ride—what stories or people along the way have inspired you?  

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.”   He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.”   In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support.     https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and  he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections.   The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs.     Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs.   In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later   XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide).   The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems.     Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity   XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study.   “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries.   They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment.   https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX   Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year.   The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app.  https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones   XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care.  Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations.   The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe.   The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market.   The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems.   Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation.   Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options.   It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems.   “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra.   Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes.   The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations.   ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna.   The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape.   “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.”   https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m   XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results…   Well maybe that's overplaying it a little.   Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better.   Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/   XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic.   Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana.   “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp.   He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could.     “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp.   He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s.   “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp.   Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes.     Bob credits his late wife, Donna, for helping him beat the odds.   “She has been key in that I always ate on time.”   They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner.   “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp.     Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps.   “I'm not satisfied with the sensors they have today. I just don't think they're accurate.”   To many, Bob's survival is extraordinary. To him, it's luck.   “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp.     And through it all, optimism has been his compass.   “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp.   He still welds nearly every day. Not because he has to, but because it keeps him going.   “As long as I keep doing something like this, I will not be in the nursing home,” said Delp.   https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond.  Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?:   An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.   

Why Writing a Book in 2025 Is a Game-Changer for Entrepreneurs: Expert Insights from Book Coach Jennifer CrosswhiteIn today's fast-moving business world, standing out as a thought leader requires more than just expertise—it requires authority. In this episode of The Thoughtful Entrepreneur, host Josh Elledge sits down with Jennifer Crosswhite, seasoned book coach, editor, and CEO and Owner of Tandem Services Inc., to discuss why writing a book in 2025 is one of the most powerful moves an entrepreneur, coach, or CEO can make. Jennifer shares her experience navigating both traditional and self-publishing, revealing actionable strategies for turning your ideas into a book that builds credibility, influence, and lasting impact.Why a Book is Your Ultimate Authority ToolWriting a book in 2025 is not just about putting words on a page—it's about creating a strategic asset that can transform your business and personal brand. Jennifer emphasizes that a book functions as a tangible symbol of authority, often called a “$10 business card,” and provides a global platform for your message. Beyond credibility, books open doors to speaking engagements, media appearances, consulting opportunities, and strategic partnerships that would otherwise be out of reach.Another important point Jennifer makes is that publishing today is democratized. With self-publishing, hybrid models, and AI tools, entrepreneurs now have unprecedented access to producing high-quality content while directly connecting with their audience. AI can help with research, outlining, and drafting—but the unique voice and expertise of the author remain irreplaceable.Finally, a book is not about filling pages—it's about transformation. Jennifer stresses the importance of curating ideas, reverse-engineering your content for impact, and keeping your audience's journey front and center. When done strategically, a book becomes a tool to guide, inspire, and educate readers, creating measurable business growth and influence.About Jennifer CrosswhiteJennifer Crosswhite is a seasoned book coach, editor, and CEO and Owner of Tandem Services Inc., with extensive experience in traditional publishing, self-publishing, and coaching first-time authors. She helps entrepreneurs, thought leaders, and business owners craft books that establish authority, attract opportunities, and create lasting impact for readers and their businesses.About Tandem Services Inc.Tandem Services Inc. is a full-service coaching and publishing company dedicated to guiding authors from concept to published work. From strategic planning and outlining to editing and coaching, Tandem Services empowers business leaders to write books that not only position them as experts but also open doors to new opportunities, audiences, and revenue streams.Links Mentioned in this EpisodeTandem Services Inc. WebsiteJennifer Crosswhite on LinkedInKey Episode HighlightsWhy writing a book is the ultimate authority and credibility builder in 2025.How self-publishing and AI tools are changing the modern publishing landscape.Common misconceptions about book writing: it's not about page count, it's about transformation.Jennifer's two-step brainstorming process: brain dump and organization for maximum impact.The benefits of working with a book coach: accountability, expert feedback, and positioning your book for success.ConclusionWriting a book in 2025 is more than a creative project—it's a strategic business move that can set you apart, build authority, and expand your reach globally. Jennifer Crosswhite's...

In this episode of Thriving in Tandem, Robert and Kay Lee unpack the dangers of making impulsive business or investment decisions based on hype, emotion, or pressure. Whether it's a flashy marketing strategy, a “can't miss” real estate deal, or a new business venture, many married entrepreneurs get swept up in the excitement without counting the cost. Drawing from real-life lessons—some painful—they discuss how couples can safeguard their finances and their marriage by slowing down, asking the right questions, and aligning their risk tolerance. Together, they walk through key decision-making pitfalls: FOMO, emotional buying, and lack of due diligence. You'll learn how to avoid being manipulated by urgency or scarcity tactics and how to test business ideas in small ways before investing big. Most importantly, Robert and Kay Lee show how couples can communicate through their differences in risk tolerance and move forward in unity—because your business should grow your wealth, not blow up your relationship. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Key Takeaways: Risk tolerance matters—especially in marriage. Know yours, know your spouse's, and talk about it before you're faced with a big decision. Don't let hype override wisdom. Watch out for pressure tactics like limited-time offers or guaranteed returns—they're red flags. Test before you invest. Whether it's marketing or real estate, start small. Use low-cost or no-cost methods to gauge results first. Emotions + speed = danger. Fast decisions made under emotional pressure are more likely to backfire. Take time to assess the risk. Do your due diligence. Ask hard questions. Get wise counsel. Research independently. Don't rely solely on what a salesperson says.